374 related articles for article (PubMed ID: 32597237)
1. The combination of neutrophil-to-lymphocyte ratio and platelet correlation parameters in predicting the no-reflow phenomenon after primary percutaneous coronary intervention in patients with ST-segment elevation myocardial infarction.
Zhang Q; Hu M; Sun J; Ma S
Scand Cardiovasc J; 2020 Dec; 54(6):352-357. PubMed ID: 32597237
[TBL] [Abstract][Full Text] [Related]
2. Comparison of neutrophil-to-lymphocyte ratio and mean platelet volume in the prediction of adverse events after primary percutaneous coronary intervention in patients with ST-elevation myocardial infarction.
Machado GP; Araujo GN; Carpes CK; Lech M; Mariani S; Valle FH; Bergoli LCC; Gonçalves SC; Wainstein RV; Wainstein MV
Atherosclerosis; 2018 Jul; 274():212-217. PubMed ID: 29803159
[TBL] [Abstract][Full Text] [Related]
3. Predictive value of admission red cell distribution width-platelet ratio for no-reflow phenomenon in acute ST segment elevation myocardial infarction undergoing primary percutaneous coronary intervention.
Celık T; Balta S; Demır M; Yıldırım AO; Kaya MG; Ozturk C; Demırkol S; Unlu M; Kılıc S; Aydın İ; Iyısoy A
Cardiol J; 2016; 23(1):84-92. PubMed ID: 26503078
[TBL] [Abstract][Full Text] [Related]
4. Prognostic Value of Pre-Infarction Angina Combined with Mean Platelet Volume to Lymphocyte Count Ratio for No-Reflow and Short-Term Mortality in Patients with ST-Segment Elevation Myocardial Infarction Undergoing Percutaneous Coronary Intervention.
Chen X; Meng Y; Shao M; Zhang T; Han L; Zhang W; Zhang H; Hai H; Li G
Med Sci Monit; 2020 Jan; 26():e919300. PubMed ID: 31949123
[TBL] [Abstract][Full Text] [Related]
5. Utility of Hematological Parameters in Predicting No-Reflow Phenomenon After Primary Percutaneous Coronary Intervention in Patients With ST-Segment Elevation Myocardial Infarction.
Wang Z; Ren L; Liu N; Peng J
Clin Appl Thromb Hemost; 2018 Oct; 24(7):1177-1183. PubMed ID: 29552915
[TBL] [Abstract][Full Text] [Related]
6. Predictors of No-Reflow Phenomenon in Young Patients With Acute ST-Segment Elevation Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention.
Celik T; Balta S; Ozturk C; Kaya MG; Aparci M; Yildirim OA; Demir M; Unlu M; Demirkol S; Kilic S; Iyisoy A
Angiology; 2016 Aug; 67(7):683-9. PubMed ID: 26369341
[TBL] [Abstract][Full Text] [Related]
7. Impact of platelet inhibition level on subsequent no-reflow in patients undergoing primary percutaneous coronary intervention for ST-segment elevation myocardial infarction.
Aitmokhtar O; Paganelli F; Benamara S; Azaza A; Bonello L; Hamza O; Seddiki S; Benathmane T; Saidane M; Bouzid A; Kara M; Sik A; Azzouz A; Harbi F; Monsuez JJ; Benkhedda S
Arch Cardiovasc Dis; 2017 Nov; 110(11):626-633. PubMed ID: 28583820
[TBL] [Abstract][Full Text] [Related]
8. Correlation of platelet-to-lymphocyte ratio and neutrophil-to-lymphocyte ratio with thrombolysis in myocardial infarction frame count in ST-segment elevation myocardial infarction.
Vakili H; Shirazi M; Charkhkar M; Khaheshi I; Memaryan M; Naderian M
Eur J Clin Invest; 2017 Apr; 47(4):322-327. PubMed ID: 28177528
[TBL] [Abstract][Full Text] [Related]
9. New CHA
Zhang QY; Ma SM; Sun JY
BMC Cardiovasc Disord; 2020 Jul; 20(1):346. PubMed ID: 32711475
[TBL] [Abstract][Full Text] [Related]
10. Relationship Between Systemic Inflammation Index and No-Reflow Phenomenon in Patients With ST-Segment Elevation Myocardial Infarction.
Çelik MC; Karayiğit O; Ozkan C; Dolu AK; Kalçık M
Angiology; 2023 Apr; 74(4):387-394. PubMed ID: 35857618
[TBL] [Abstract][Full Text] [Related]
11. Usefulness of Mean Platelet Volume-to-Lymphocyte Ratio for Predicting Angiographic No-Reflow and Short-Term Prognosis After Primary Percutaneous Coronary Intervention in Patients With ST-Segment Elevation Myocardial Infarction.
Kurtul A; Acikgoz SK
Am J Cardiol; 2017 Aug; 120(4):534-541. PubMed ID: 28633762
[TBL] [Abstract][Full Text] [Related]
12. Platelet-Lymphocyte ratio is a predictor for the development of no-reflow phenomenon in patients with ST-segment elevation myocardial infarction after thrombus aspiration.
Şenöz O; Emren SV; Erseçgin A; Yapan Emren Z; Gül İ
J Clin Lab Anal; 2021 Jun; 35(6):e23795. PubMed ID: 33945171
[TBL] [Abstract][Full Text] [Related]
13. Elevated neutrophil-to-lymphocyte ratio can predict procedural adverse events in patients with ST-elevation myocardial infarction undergoing primary percutaneous coronary intervention.
Pinheiro Machado G; Araujo GN; Carpes CK; Lech MC; Mariani S; Valle FH; Bergoli LCC; Wainstein RV; Wainstein MV
Coron Artery Dis; 2019 Jan; 30(1):20-25. PubMed ID: 30334819
[TBL] [Abstract][Full Text] [Related]
14. [Relation of admission neutrophil/lymphocyte ratio to angiographic no-reflow phenomenon in patients with ST-elevated myocardial infarction undergoing primary coronary intervention].
Niu X; Zhang Y; He S; Chen D; Yan D; Yao Y
Zhonghua Liu Xing Bing Xue Za Zhi; 2014 Jul; 35(7):856-60. PubMed ID: 25294082
[TBL] [Abstract][Full Text] [Related]
15. Comparison of syntax score and syntax score II to predict "no reflow phenomenon" in patients with ST-segment elevation myocardial infarction.
Yesin M; Çağdaş M; Kalçık M; Uluganyan M; Efe SÇ; Rencüzoğulları İ; Karabağ Y; Gürsoy MO; Karakoyun S
Int J Cardiovasc Imaging; 2017 Dec; 33(12):1883-1889. PubMed ID: 28664479
[TBL] [Abstract][Full Text] [Related]
16. Predictive value of admission platelet volume indices for in-hospital major adverse cardiovascular events in acute ST-segment elevation myocardial infarction.
Celik T; Kaya MG; Akpek M; Gunebakmaz O; Balta S; Sarli B; Duran M; Demirkol S; Uysal OK; Oguzhan A; Gibson CM
Angiology; 2015 Feb; 66(2):155-62. PubMed ID: 24301422
[TBL] [Abstract][Full Text] [Related]
17. HEMATOLOGICAL MARKERS OF THE NO-REFLOW PHENOMEN ON IN-PATIENTS UNDERGOING PRIMARY PERCUTANEOUS CORONARY INTERVENTION.
Şahinkuş S; Cakar M; Yaylacı S; Aydın E; Can Y; Kocayigit I; Osken A; Akdemir R; Gunduz H
Georgian Med News; 2016 May; (254):26-32. PubMed ID: 27348163
[TBL] [Abstract][Full Text] [Related]
18. The relationship between neutrophil counts on admission and angiographic no-reflow after primary percutaneous coronary intervention in patients with ST-segment elevation myocardial infarction.
Wang Z; Ren L; Lei L; Ye H; Peng J
Acta Cardiol; 2016 Apr; 71(2):241-6. PubMed ID: 27090048
[TBL] [Abstract][Full Text] [Related]
19. The relationship between atherogenic index of plasma and no-reflow in patients with acute ST-segment elevation myocardial infarction who underwent primary percutaneous coronary intervention.
Süleymanoğlu M; Rencüzoğulları İ; Karabağ Y; Çağdaş M; Yesin M; Gümüşdağ A; Çap M; Gök M; Yıldız İ
Int J Cardiovasc Imaging; 2020 May; 36(5):789-796. PubMed ID: 31919706
[TBL] [Abstract][Full Text] [Related]
20. Neutrophil-lymphocyte ratio and platelet-lymphocyte ratio combination can predict prognosis in patients with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention.
Çiçek G; Açıkgoz SK; Bozbay M; Altay S; Uğur M; Uluganyan M; Uyarel H
Angiology; 2015 May; 66(5):441-7. PubMed ID: 24834932
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
